CD4 and neoplasm: Reciprocally, NK cells can activate DCs, enhancing their ability to produce pro-inflammatory cytokines and stimulate T helper and cytotoxic T lymphocyte responses of tumor-specific CD4+ and CD8+ T cells [4,5,7,8].